ABL Diagnostics ABLD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €3.18
- Day Range
- €3.18–3.18
- 52-Week Range
- €3.18–9.70
- Bid/Ask
- €2.00 / €5.00
- Market Cap
- €51.24 Mil
- Volume/Avg
- 50 / 80
Key Statistics
- Price/Earnings (Normalized)
- 45.02
- Price/Sales
- 0.55
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 21
- Website
- https://www.abldiagnostics.com
Valuation
Metric
|
ABLD
|
---|---|
Price/Earnings (Normalized) | 45.02 |
Price/Book Value | 7.64 |
Price/Sales | 0.55 |
Price/Cash Flow | — |
Price/Earnings
ABLD
Financial Strength
Metric
|
ABLD
|
---|---|
Quick Ratio | 1.47 |
Current Ratio | 2.26 |
Interest Coverage | — |
Quick Ratio
ABLD
Profitability
Metric
|
ABLD
|
---|---|
Return on Assets (Normalized) | 3.92% |
Return on Equity (Normalized) | 8.45% |
Return on Invested Capital (Normalized) | 6.24% |
Return on Assets
ABLD
Health Information Services Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Plfph | $41.1 Bil | |
VEEV
| Veeva Systems Inc Class A | Ndmqkphh | Ktkzc | $37.6 Bil | |
MTHRF
| M3 Inc | — | Tfzyfph | $9.6 Bil | |
MTHRY
| M3 Inc ADR | — | Zvrvyzl | $9.6 Bil | |
PMCUF
| Pro Medicus Ltd | — | Dtfwz | $7.0 Bil | |
HQY
| HealthEquity Inc | — | Mmjdyf | $6.9 Bil | |
RCM
| R1 RCM Inc | — | Kybr | $5.5 Bil | |
DOCS
| Doximity Inc Class A | — | Nbyphxm | $5.0 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Kwk | $4.4 Bil | |
EVH
| Evolent Health Inc Class A | — | Gfwk | $3.7 Bil |